From Health Canada:
Lack of Survival Benefit and Increased Incidence of Tumour Haemorrhage in Association with IRESSA® in Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN ...more
Wednesday, December 13, 2006
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment